ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,369Medicare Part D Prescriptions Filled, Including Refills

Rank: 74 out of 2456

$598K Total Retail Price of All Prescriptions

Rank: 160 out of 2456

437 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 437 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 437 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 12,380 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 735 643 1 2
LISINOPRIL 636 556 2 1
WARFARIN SODIUM 549 462 3 9
FUROSEMIDE 549 491 3 8
LEVOTHYROXINE SODIUM 489 450 5 4
OMEPRAZOLE 435 345 6 3
METOPROLOL TARTRATE 409 390 7 10
ATENOLOL 396 338 8 6
CITALOPRAM HBR 352 330 9 14
TRAZODONE HCL 303 260 10 17
MIRTAZAPINE 283 280 11 29
AMLODIPINE BESYLATE 238 207 12 5
DONEPEZIL HCL 213 213 13 23
NAMENDA 208 208 14 42
METFORMIN HCL 205 147 15 11
POTASSIUM CHLORIDE 199 199 16 33
GABAPENTIN 197 173 17 16
HYDROCODONE-ACETAMINOPHEN 189 113 S3 18 20
METOPROLOL SUCCINATE 180 152 19 13
HYDROCHLOROTHIAZIDE 149 138 20 7
POLYETHYLENE GLYCOL 3350 144 141 21 64
OLANZAPINE 133 109 22 57
DIVALPROEX SODIUM 130 116 23 51
NYSTATIN 123 98 24 99
GLIPIZIDE 119 89 25 46
TRIAMTERENE-HCTZ 108 107 26 53
ATORVASTATIN CALCIUM 106 106 27 12
RANITIDINE HCL 104 103 28 31
CLOPIDOGREL 97 91 29 55
QUETIAPINE FUMARATE 97 93 29 47
SERTRALINE HCL 96 96 31 21
AZITHROMYCIN 95 76 32 60
TAMSULOSIN HCL 89 75 33 32
ADVAIR DISKUS 88 67 34 36
DIGOXIN 88 87 34 49
PRAVASTATIN SODIUM 87 49 36 15
IPRATROPIUM-ALBUTEROL 82 80 37 85
FLUOXETINE HCL 78 39 38 45
ISOSORBIDE MONONITRATE ER 74 72 39 48
RISPERIDONE 71 53 40 50
PROAIR HFA 70 47 41 22
CYMBALTA 68 30 42 65
CLOTRIMAZOLE-BETAMETHASONE 68 67 42 182
METHADONE HCL 67 66 S2 44 135
SULFAMETHOXAZOLE-TRIMETHOPRIM 66 47 45 147
NIFEDIPINE ER 66 54 45 61
LANTUS 65 64 47 44
FINASTERIDE 65 65 47 66
VENLAFAXINE HCL ER 65 41 47 92
GLYBURIDE 65 65 R 47 40
PREDNISONE 64 54 51 39
PLAVIX 63 59 52 79
OXYCODONE-ACETAMINOPHEN 63 49 S2 52 35
CYCLOBENZAPRINE HCL 63 23 R 52 77
DIOVAN 59 59 55 26
LEVETIRACETAM 57 32 56 90
ALLOPURINOL 56 47 57 27
FLUTICASONE PROPIONATE 55 43 58 30
OXYBUTYNIN CHLORIDE ER 55 49 58 94
CIPROFLOXACIN HCL 55 46 58 87
CARBIDOPA-LEVODOPA 54 54 61 82
DILTIAZEM 24HR CD 51 51 62 113
FAMOTIDINE 50 50 63 84
ZOLPIDEM TARTRATE 50 46 63 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.